Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion for Chronic Kidney Disease
This trial will test if it is safe to give people with chronic kidney disease mesenchymal stem cells, which may help treat the disease.
- Chronic Kidney Disease
- Diabetic Kidney Disease
- Type 2 Diabetes
- Type 1 Diabetes
1 Primary · 0 Secondary · Reporting Duration: 22 months
2 Treatment Groups
Dose Arm 2
1 of 2
Dose Arm 1
1 of 2
40 Total Participants · 2 Treatment Groups
Primary Treatment: Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 30 - 80 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants have been recruited for this trial?
"Yes, the current data posted on clinicaltrials.gov confirms that this medical study is actively recruiting participants. This research was first launched on October 7th 2021 and last updated November 9th 2022. The trial necessitates 40 patients from two different sites to be enrolled in order for it to successfully conclude." - Anonymous Online Contributor
Are there any vacancies for study participants still available?
"Affirmative. According to the clinicaltrials.gov information, this medical study is currently gathering participants with first posting date of October 7th 2021 and last update on November 9th 2022. 40 patients need to be recruited from two distinct locations." - Anonymous Online Contributor
Is the target population of this research project limited to individuals over 25 years of age?
"This trial is accepting participants aged between 30 and 80 years." - Anonymous Online Contributor
Has the FDA sanctioned a single-dose approach utilizing allogeneic adipose-derived mesenchymal stem cells?
"We deem the safety of Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion to be a 1 due to being in Phase 1; there is minimal evidence that its safe and effective." - Anonymous Online Contributor
Is it possible to become part of this experiment?
"Candidates hoping to be admitted into this research project must meet two requirements - they have a diagnosis of diabetes mellitus, type 2 and their age is between 30-80. Currently, the trial desires around 40 participants in total." - Anonymous Online Contributor